DDX41 and Zika virus infectious disease: In vitro, cross-reactive murine DENV Abs can enhance ZIKV infection22,59 and human DENV Abs can neutralize5,9–11,60,61 or enhance9,10,12,22,62,63 ZIKV infection depending on their epitope specificity and avidity.